FTM

First Turn Management Portfolio holdings

AUM $666M
1-Year Est. Return 86.8%
This Quarter Est. Return
1 Year Est. Return
+86.8%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$536M
AUM Growth
+$40M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1
+$15.9M
2
+$14.2M
3
+$9.57M
4
NAMS icon
NewAmsterdam Pharma
NAMS
+$9.44M
5
AKRO icon
Akero Therapeutics
AKRO
+$6.11M

Top Sells

1
+$13.4M
2
+$13.4M
3
+$13M
4
VRNA
Verona Pharma
VRNA
+$11.9M
5
PCVX icon
Vaxcyte
PCVX
+$10.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAMS icon
26
NewAmsterdam Pharma
NAMS
$4.35B
$9.44M 1.76%
+521,097
HQY icon
27
HealthEquity
HQY
$8.77B
$8.47M 1.58%
80,880
-3,086
SPRY icon
28
ARS Pharmaceuticals
SPRY
$812M
$7.96M 1.48%
455,953
-213,057
VERA icon
29
Vera Therapeutics
VERA
$1.81B
$7.3M 1.36%
309,666
-313,946
SLNO icon
30
Soleno Therapeutics
SLNO
$2.65B
$7.23M 1.35%
86,332
+57,217
HROW icon
31
Harrow
HROW
$1.51B
$6.99M 1.3%
228,761
+39,932
AKRO icon
32
Akero Therapeutics
AKRO
$4.47B
$6.11M 1.14%
+114,554
ALNY icon
33
Alnylam Pharmaceuticals
ALNY
$59.3B
$5.83M 1.09%
+17,879
KALV icon
34
KalVista Pharmaceuticals
KALV
$688M
$2.42M 0.45%
+214,138
BBNX
35
Beta Bionics
BBNX
$1.2B
$2.29M 0.43%
+157,194
EXAS icon
36
Exact Sciences
EXAS
$12.7B
– –
-300,909
GKOS icon
37
Glaukos
GKOS
$5.17B
– –
-136,241
MLTX icon
38
MoonLake Immunotherapeutics
MLTX
$905M
– –
-179,196
PCVX icon
39
Vaxcyte
PCVX
$6.37B
– –
-276,905
PRAX icon
40
Praxis Precision Medicines
PRAX
$4.66B
– –
-71,775
SWTX
41
DELISTED
SpringWorks Therapeutics
SWTX
– –
-304,076
BPMC
42
DELISTED
Blueprint Medicines
BPMC
– –
-92,033
1
2